Zhejiang Wolwo Bio-Pharmaceutical Dividends and Buybacks
Dividend criteria checks 4/6
Zhejiang Wolwo Bio-Pharmaceutical is a dividend paying company with a current yield of 0.79% that is well covered by earnings.
Key information
0.8%
Dividend yield
0.7%
Buyback Yield
| Total Shareholder Yield | 1.5% |
| Future Dividend Yield | 0.7% |
| Dividend Growth | 0.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.185 |
| Payout ratio | 31% |
Recent dividend and buyback updates
Recent updates
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.'s (SZSE:300357) P/E Is Still On The Mark Following 39% Share Price Bounce
Sep 30
These 4 Measures Indicate That Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) Is Using Debt Reasonably Well
Sep 26Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) Has Announced That Its Dividend Will Be Reduced To CN¥0.185
Jun 30Investor Optimism Abounds Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357) But Growth Is Lacking
May 27Calculating The Fair Value Of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SZSE:300357)
May 07Is Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) A Risky Investment?
Mar 22Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300357's dividend payments have been volatile in the past 10 years.
Growing Dividend: 300357's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Zhejiang Wolwo Bio-Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300357) | 0.8% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Pharmaceuticals) | 1.7% |
| Analyst forecast (300357) (up to 3 years) | 0.7% |
Notable Dividend: 300357's dividend (0.79%) is higher than the bottom 25% of dividend payers in the CN market (0.56%).
High Dividend: 300357's dividend (0.79%) is low compared to the top 25% of dividend payers in the CN market (2.17%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (31%), 300357's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (65.8%), 300357's dividend payments are covered by cash flows.